A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, active-control, multicenter trial comparing two
oxaliplatin/Avastin-based treatment sequences as first-line therapy for metastatic colorectal
cancer. The study is designed to compare the efficacy of these two treatment sequences with
respect to progression free survival (PFS) and overall survival.